Search clinical trials for: lenalidomide, bendamustine, rituximab
Total 4131 results
-
University of Wisconsin, MadisonGenentech, Inc.; Celgene CorporationWithdrawnChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)
-
Lund University HospitalMundipharma Pte Ltd.; Roche Pharma AG; CelgeneCompletedMantle Cell LymphomaFinland, Denmark, Norway, Sweden
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Celgene CorporationCompletedRefractory/Relapsed Indolent Non-Hodgkin LymphomaUnited States
-
The Lymphoma Academic Research OrganisationRecruitingMarginal Zone LymphomaFrance
-
Fondazione Italiana Linfomi ONLUSCompleted
-
German CLL Study GroupRoche Pharma AG; Celgene; Mundipharma Research GmbH & Co KGCompletedChronic Lymphocytic LeukemiaGermany
-
Medical University of ViennaNot yet recruiting
-
MD Anderson International Spain SACelgene CorporationCompletedChronic Lymphocytic LeukemiaSpain
-
CelgeneThe Lymphoma Academic Research OrganisationActive, not recruitingFollicular LymphomaUnited States, Japan
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed
-
Swiss Group for Clinical Cancer ResearchCompleted
-
The Lymphoma Academic Research OrganisationCelgene CorporationActive, not recruitingFollicular LymphomaSpain, Canada, France, Australia, Italy, Belgium, Germany, Portugal
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLymphoma | Neurotoxicity | Therapy-related ToxicityUnited States, Canada
-
Georgetown UniversityCelgene Corporation; CephalonCompletedNon-Hodgkin's Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone LymphomaUnited States
-
University of Wisconsin, MadisonGenentech, Inc.; Celgene CorporationCompletedLymphoma, Non-Hodgkin | Small Lymphocytic Lymphoma | Lymphoid LeukemiaUnited States
-
Georg Hess, MDWyeth is now a wholly owned subsidiary of Pfizer; Mundipharma Pte Ltd.CompletedFollicular Lymphoma | Mantle Cell LymphomaGermany
-
Samsung Medical CenterUnknownMantle Cell LymphomaKorea, Republic of
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedChronic Lymphocytic LeukemiaItaly
-
The Lymphoma Academic Research OrganisationTerminated
-
University of Wisconsin, MadisonCelgene CorporationCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
National Research Center for Hematology, RussiaUnknown
-
Gruppo Italiano Studio LinfomiCompletedBendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative DisordersRelapsed or Refractory Chronic Lymphoproliferative DisordersItaly
-
Swiss Group for Clinical Cancer ResearchTerminatedLymphomaSwitzerland, Norway, Sweden
-
Fondazione Italiana Linfomi ONLUSUnknownDiffuse Large B-cell LymphomaItaly
-
International Extranodal Lymphoma Study Group (IELSG)CompletedMarginal Zone B-cell LymphomaItaly, France
-
Hoffmann-La RocheRecruitingLymphomaKorea, Republic of, United States, France, Brazil, China, Spain, Australia, Sweden, Taiwan, Italy, United Kingdom
-
Seoul National University HospitalChonbuk National University Hospital; Seoul National University Bundang Hospital and other collaboratorsCompletedMarginal Zone B-cell LymphomaKorea, Republic of
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
CephalonCompletedNon-Hodgkin's LymphomaUnited States, Australia, Canada
-
Grupo Oncológico para el Tratamiento y el Estudio...UnknownFollicular Non-Hodgking´s Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line.Spain
-
PharmatechCephalonCompletedDiffuse Large B-Cell LymphomaUnited States
-
University of GöttingenRoche Pharma AG; Mundipharma Research GmbH & Co KGCompleted
-
Astellas Pharma Europe B.V.CompletedChronic Lymphocytic LeukemiaRussian Federation
-
Astellas Pharma Europe B.V.CompletedLymphoma, Non-HodgkinRussian Federation
-
Asan Medical CenterCheolwon SuhRecruitingDiffuse Large B Cell LymphomaKorea, Republic of
-
Helse FonnaCompletedAutoimmune Hemolytic Anemia | Cold Agglutinin DiseaseFinland, Denmark, Norway
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)WithdrawnDiffuse Large B-Cell LymphomaUnited States
-
Czech CLL Study GroupCompleted
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B Chronic Lymphocytic LeukemiaUnited States
-
University Hospital TuebingenArbeitsgemeinschaft fur Internistische Onkologie; German Sarcoma GroupCompleted
-
Fondazione Italiana Linfomi ONLUSCompletedWaldenstrom's MacroglobulinemiaItaly
-
Fondazione Italiana Linfomi - ETSActive, not recruiting
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicFinland, France, Spain, Portugal, Turkey, United Kingdom, Sweden, Tunisia
-
University of RochesterMillennium Pharmaceuticals, Inc.; CephalonCompletedNon-Hodgkin's LymphomaUnited States
-
Institut Paoli-CalmettesCompletedNon-Hodgkin LymphomaFrance
-
Roswell Park Cancer InstituteCelgeneCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Withdrawn